NATCO Pharma LimitedNSE: NATCOPHARM

Press Release Nov 14 2023

· Issued by NATCO Pharma Limited

Filed with NSE ·

Natco Pharma Limited has informed the Exchange regarding a press release dated November 14, 2023, titled "NATCO records ₹1060.8 Crore consolidated revenue and ₹369 Croreof profit after tax, for the Second Quarter, FY2024".

View Attachment

6ix hasn’t read this filing yet.

NATCO Pharma Limited on 6ix

In the deck

Earlier from NATCO Pharma

Later from NATCO Pharma

All NATCO Pharma news releases